Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00330
|
|||||
| Drug Name |
Cephalexin
|
|||||
| Synonyms |
7-(D-2-Amino-2-phenylacetamido)-3-methyl-delta (sup 3)-cephem-4-carboxylic acid; 7-(D-2-Amino-2-phenylacetamido)-3-methyl-delta3-cephem-4-carboxylic acid; 7-(D-alpha-Aminophenylacetamido)desacetoxycephalosporanic acid; Adcadina; Ades[prex; Alcephin; Alexin; Alsporin; Ambal; Aristosporin; Azabort; Bactopenor; Beliam; Biocef; CEX; Carnosporin; Cefa-iskia; Cefablan; Cefacet; Cefadal; Cefadin; Cefadina; Cefalekey; Cefaleksin; Cefalessina; Cefalessina [DCIT]; Cefalexgobens; Cefalexin; Cefalexin (JP15); Cefalexin Scand Pharm; Cefalexin Sodium; Cefalexin generics; Cefalexin hydrate; Cefalexin monohydrate; Cefalexin.H2O; Cefalexina; Cefalexina Northia; Cefalexina Richet; Cefalexina [INN-Spanish]; Cefalexine; Cefalexine [INN-French]; Cefalexinum; Cefalexinum [INN-Latin]; Cefalin; Cefalival; Cefaloto; Cefaseptin; Cefax; Ceffanex; Cefibacter; Ceflax; Ceforal; Cefovit; Celexin; Cepastar; Cepexin; Cephacillin; Cephalex von ct; Cephalexin (anhydrous); Cephalexin 1-hydrate; Cephalexin 1-wasser; Cephalexin [USAN:BAN]; Cephalexin hydrate; Cephalexin monohydrate; Cephalexin(USP); Cephalexin, (6R-(6alpha,7beta))-Isomer; Cephalexin.H2O; Cephalexine; Cephalexinum; Cephalobene; Cephanasten; Cephaxin; Cephin; Cepol; Ceporex; Ceporex Forte; Ceporexin; Ceporexin-E; Ceporexine; Check; Cophalexin; Cusisporina-Cefalox; Domucef; Doriman; Durantel; Durantel DS; Ed A-Ceph; Efemida; Erocetin; Factagard; Felexin; Fexin; Henina Oral; Ibilex; Ibrexin; Inphalex; KS-1134; Karilexina; Kefalospes; Keflet; Keflex; Keflex (TN); Kefolan; Keforal; Keftab; Keftab (TN); Kekrinal; Kidolex; L-Keflex; Lafarine; Larixin; Lenocef; Lexibiotico; Lilly 66873; Loisine; Lonflex; Lopilexin; Losporal; Madlexin; Maksipor; Mamalexin; Mamlexin; Medolexin; Medoxine; Neokef; Neolexina; Noveol; Novolexin; Nufex; Oracef; Oriphex; Oroxin; Ortisporina; Ospexin; Palitrex; Panixine Disperdose; Panixine disperdose (TN); Pectril; Prindex; Pyassan; Rilexine; Roceph; Roceph Distab; Rogevil; S 6437; SQ 20248; Sanaxin; Sartosona; Sencephalin; Sepexin; Servicef; Servispor; Sialexin; Sinthecillin; Sintolexyn; Sporicef; Sporidex; Sporidex (TN); Syncl; Syncle; Synecl; Tepaxin; Theratrex; Tokiolexin; Uphalexin; Viosporine; Voxxim; Winlex; Zabytrex; Zozarine
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | Gram-positive bacteria infections [ICD11: 1A00-1H0Z] | Approved | [1] | |||
| Therapeutic Class |
Antibiotics
|
|||||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C16H17N3O4S
|
|||||
| Canonical SMILES |
CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O
|
|||||
| InChI |
InChI=1S/C16H17N3O4S/c1-8-7-24-15-11(14(21)19(15)12(8)16(22)23)18-13(20)10(17)9-5-3-2-4-6-9/h2-6,10-11,15H,7,17H2,1H3,(H,18,20)(H,22,23)/t10-,11-,15-/m1/s1
|
|||||
| InChIKey |
ZAIPMKNFIOOWCQ-UEKVPHQBSA-N
|
|||||
| CAS Number |
CAS 15686-71-2
|
|||||
| Pharmaceutical Properties | Molecular Weight | 347.4 | Topological Polar Surface Area | 138 | ||
| Heavy Atom Count | 24 | Rotatable Bond Count | 4 | |||
| Hydrogen Bond Donor Count | 3 | Hydrogen Bond Acceptor Count | 6 | |||
| XLogP |
0.6
|
|||||
| PubChem CID | ||||||
| PubChem SID |
103682056
, 104029668
, 104300019
, 108667050
, 11466386
, 11467506
, 11486112
, 121277919
, 124658838
, 124766007
, 126672951
, 129874110
, 134221931
, 134337733
, 134991978
, 135692166
, 136367997
, 137001569
, 137240151
, 139157607
, 144089066
, 14778344
, 14876054
, 26719711
, 29215501
, 34669971
, 46386774
, 46506749
, 47291384
, 47515590
, 47811031
, 48259499
, 48415740
, 48631157
, 49698453
, 50050891
, 50064641
, 50109863
, 56314309
, 57310443
, 594576
, 625390
, 7847329
, 7978893
, 79988419
, 8169783
, 85788571
, 87246423
, 9112
, 92308234
|
|||||
| ChEBI ID |
CHEBI:3534
|
|||||
| TTD Drug ID | ||||||
| DT(s) Transporting This Drug | MATE1 | Transporter Info | Multidrug and toxin extrusion protein 1 | Substrate | [2] | |
| PEPT1 | Transporter Info | Peptide transporter 1 | Substrate | [3] | ||
| PEPT2 | Transporter Info | Peptide transporter 2 | Substrate | [4] | ||
| Drug-Transporter Activity Data | ||||||
| Drug-Transporter Activity Data | PEPT1 | Transporter Info | Km = 7.97 microM | Human enterocyte-like 2 cells (Caco-2)-PEPT1 | [5] | |
| References | ||||||
| 1 | Cephalexin was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019) | |||||
| 2 | Reduced renal clearance of a zwitterionic substrate cephalexin in MATE1-deficient mice. J Pharmacol Exp Ther. 2010 Aug;334(2):651-6. | |||||
| 3 | Direct evidence for efficient transport and minimal metabolism of L-cephalexin by oligopeptide transporter 1 in budded baculovirus fraction. Biol Pharm Bull. 2009 Aug;32(8):1459-61. | |||||
| 4 | Transport characteristics of a novel peptide transporter 1 substrate, antihypotensive drug midodrine, and its amino acid derivatives. J Pharmacol Exp Ther. 2006 Jul;318(1):455-60. | |||||
| 5 | Effects of progesterone and norethisterone on cephalexin uptake in the human intestinal cell line Caco-2. Biol Pharm Bull. 2004 Apr;27(4):559-63. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.